|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/14 | |
| A61K 38/00 | |||
| A61K 38/48 |
| (11) | Number of the document | 2222315 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08864646.8 |
| Date of filing the European patent application | 2008-12-16 | |
| (97) | Date of publication of the European application | 2010-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2013-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/087031 |
| Date | 2008-12-16 |
| (87) | Number | WO 2009/082648 |
| Date | 2009-07-02 |
| (30) | Number | Date | Country code |
| 16230 P | 2007-12-21 | US |
| (72) |
MANKARIOUS, Samia, US
GRIFFITH, Michael, J., US
|
| (73) |
Cangene Corporation,
115 Innovation Drive, Winnipeg, Manitoba R3T 5Y3,
CA
|
| (54) | STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE |
| STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE |